Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Role of Exosomal microRNA in Cancer Drug Resistance
Qiao-ru Guo, Hui Wang, Ying-da Yan, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

Exosome-mediated metabolic reprogramming: the emerging role in tumor microenvironment remodeling and its influence on cancer progression
Enli Yang, Xuan Wang, Zhiyuan Gong, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 315
MicroRNA: trends in clinical trials of cancer diagnosis and therapy strategies
Tae‐Wan Kim, Carlo M. Croce
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 7, pp. 1314-1321
Open Access | Times Cited: 208
Molecular and cellular paradigms of multidrug resistance in cancer
Foram U. Vaidya, Abu Sufiyan Chhipa, Vinita Mishra, et al.
Cancer Reports (2020) Vol. 5, Iss. 12
Open Access | Times Cited: 157
Extracellular Vesicles: New Classification and Tumor Immunosuppression
Mona Sheta, Eman A. Taha, Yanyin Lu, et al.
Biology (2023) Vol. 12, Iss. 1, pp. 110-110
Open Access | Times Cited: 113
The Role of Tumor-Stroma Interactions in Drug Resistance Within Tumor Microenvironment
Yanghong Ni, Xiaoting Zhou, Jia Yang, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 104
Multi drug resistance in Colorectal Cancer- approaches to overcome, advancements and future success
Sumel Ashique, Mithun Bhowmick, Radheshyam Pal, et al.
Advances in Cancer Biology - Metastasis (2024) Vol. 10, pp. 100114-100114
Open Access | Times Cited: 43
Control of Invasion by Epithelial-to-Mesenchymal Transition Programs during Metastasis
Gray W. Pearson
Journal of Clinical Medicine (2019) Vol. 8, Iss. 5, pp. 646-646
Open Access | Times Cited: 127
The transformation of cancer-associated fibroblasts: Current perspectives on the role of TGF-β in CAF mediated tumor progression and therapeutic resistance
Bikash Chandra Jena, Siddik Sarkar, Lipsa Rout, et al.
Cancer Letters (2021) Vol. 520, pp. 222-232
Closed Access | Times Cited: 73
Targeted inhibition of tumor-derived exosomes as a novel therapeutic option for cancer
Ye Li, Zhuo-Kun Chen, Xu Duan, et al.
Experimental & Molecular Medicine (2022) Vol. 54, Iss. 9, pp. 1379-1389
Open Access | Times Cited: 54
Tumor-derived miR-6794-5p enhances cancer growth by promoting M2 macrophage polarization
Jae Yeon Choi, Hyun Jeong Seok, Dong Hyeon Lee, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 13
Investigating the role of exosomal long non-coding RNAs in drug resistance within female reproductive system cancers
Nooshafarin Shirani, N. Abdi, Matin Chehelgerdi, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access | Times Cited: 1
The emerging roles of exosomes in anti-cancer drug resistance and tumor progression: An insight towards tumor-microenvironment interaction
Bikash Chandra Jena, Mahitosh Mandal
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2020) Vol. 1875, Iss. 1, pp. 188488-188488
Closed Access | Times Cited: 62
Exosome‐derived miR‐210 involved in resistance to osimertinib and epithelial–mesenchymal transition in EGFR mutant non‐small cell lung cancer cells
Kakeru Hisakane, Masahiro Seike, Teppei Sugano, et al.
Thoracic Cancer (2021) Vol. 12, Iss. 11, pp. 1690-1698
Open Access | Times Cited: 42
Link of sorafenib resistance with the tumor microenvironment in hepatocellular carcinoma: Mechanistic insights
Xinchen Tian, Tinghao Yan, Fen Liu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 36
Dynamic Cancer Cell Heterogeneity: Diagnostic and Therapeutic Implications
Valérie Jacquemin, Mathieu Antoine, Geert Dom, et al.
Cancers (2022) Vol. 14, Iss. 2, pp. 280-280
Open Access | Times Cited: 33
Function and therapeutic development of exosomes for cancer therapy
Sang Bum Kim
Archives of Pharmacal Research (2022) Vol. 45, Iss. 5, pp. 295-308
Open Access | Times Cited: 33
The Role of Exosomal Non-Coding RNAs in Colorectal Cancer Drug Resistance
Dimitra Ioanna Lampropoulou, Evangelia Pliakou, Gerasimos Aravantinos, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1473-1473
Open Access | Times Cited: 30
Find new channel for overcoming chemoresistance in cancers: Role of stem cells-derived exosomal microRNAs
Ghufran Mohammed Hussein, Shaimaa M. Mohammed, Mohammed Faris, et al.
International Journal of Biological Macromolecules (2022) Vol. 219, pp. 530-537
Closed Access | Times Cited: 28
Extracellular Vesicle-Associated miRNAs and Chemoresistance: A Systematic Review
América Campos, Shayna Sharma, Andreas Obermair, et al.
Cancers (2021) Vol. 13, Iss. 18, pp. 4608-4608
Open Access | Times Cited: 38
Trojan horse treatment based on PEG-coated extracellular vesicles to deliver doxorubicin to melanoma in vitro and in vivo
Laura Pătraș, Aura E. Ionescu, Cristian V. A. Munteanu, et al.
Cancer Biology & Therapy (2021) Vol. 23, Iss. 1, pp. 1-16
Open Access | Times Cited: 37
Novel Approaches to Characterize Individual Drug Metabolism and Advance Precision Medicine
Klarissa D. Jackson, Brahim Achour, Jong‐Hwa Lee, et al.
Drug Metabolism and Disposition (2023) Vol. 51, Iss. 10, pp. 1238-1253
Open Access | Times Cited: 15
Analysis of mRNA-miRNA interaction network reveals the role of CAFs-derived exosomes in the immune regulation of oral squamous cell carcinoma
Weizhou Wang, Xue Cao, Li Bian, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 14
Mesenchymal stromal cell exosomes for drug delivery of prostate cancer treatments: a review
Chengran Wang, Yanling Feng, Xianfang Rong, et al.
Stem Cell Research & Therapy (2025) Vol. 16, Iss. 1
Open Access
Tumor microenvironment as a novel therapeutic target for lymphoid leukemias
Seyed-Reza Mousavi, S. Nouri, Arezoo Sadeghipour, et al.
Annals of Hematology (2025)
Open Access
Exosome-based approaches in cancer along with unlocking new insights into regeneration of cancer-prone tissues
Mohsen Safaei, Seyedeh Somayeh Rajabi, Mahtab Tirgar, et al.
Regenerative Therapy (2025) Vol. 29, pp. 202-216
Closed Access
Page 1 - Next Page

Scroll to top